Accountability should remain with the health care organisation and the clinicians who use the system, not the model itself. Policies must define who reviews AI outputs, who can override them, and how exceptions are documented. Clear governance protects patient rights, prevents automation bias, and keeps final care decisions anchored in professional responsibility.
Accountability When AI Advice and Clinical Judgment Diverge
Accountability does not move to the AI system just because a recommendation was generated by software. In a clinical setting, the organisation remains responsible for the governance of the tool, and the clinician remains responsible for using professional judgment, especially when patient preferences, contraindications, or contextual factors point in a different direction. That is why documented review authority, escalation routes, and override rights matter more than the model’s apparent confidence.
For health care teams, the important issue is not whether AI can produce a plausible recommendation, but whether the workflow preserves informed consent, clinical discretion, and a clear record of why a recommendation was accepted, modified, or rejected. The control problem is familiar to anyone who has seen decision support become decision replacement. NIST SP 800-53 Rev 5 Security and Privacy Controls is relevant here because accountability depends on governance, auditability, and controlled decision processes rather than blind trust in automated output. In practice, many health systems only discover the accountability gap after an AI recommendation has already been treated as the default choice rather than a reviewable input.
How AI Recommendations Should Be Used in Clinical Practice
AI recommendations should be treated as decision support, not as a substitute for the clinical relationship or the organisation’s duty of care. The practical workflow is simple in principle but easy to break in execution: the system proposes, a qualified person reviews, the patient’s circumstances are considered, and the final decision is made by the accountable care team. If the recommendation conflicts with patient preferences, the conflict itself becomes a clinical and governance signal that needs attention, not a reason to force alignment.
That means the process should make three things explicit. First, who is authorised to review the output. Second, who has the authority to override it. Third, what evidence is recorded when the AI suggestion is not followed. Without those elements, organisations can end up with recommendations that look advisory in theory but behave like directives in practice. That creates ambiguity when outcomes are later questioned, because the record may show what the model said but not why the clinician chose a different path.
- Use the AI output as one input to a broader clinical assessment.
- Compare the recommendation against patient values, contraindications, and local policy.
- Require a named reviewer when the recommendation affects treatment direction or risk.
- Record the reason for acceptance, modification, or override in the care record.
- Escalate unresolved conflicts when the AI output and the clinical judgment point to materially different actions.
This guidance breaks down when organisations deploy AI into a workflow that does not preserve review, documentation, or meaningful human discretion.
When the Standard Answer Breaks Down
Tighter governance often increases review burden, so organisations have to balance speed against traceability and clinical autonomy. That tradeoff becomes sharper in high-volume settings, where the temptation is to let the AI output become the default because it is faster to accept than to question.
There are also edge cases where accountability is shared across several layers. A vendor may supply the model, but that does not make the vendor accountable for the bedside decision. A hospital may approve the tool, but the individual clinician still has to exercise judgment in the moment. In some jurisdictions and care pathways, formal guidance is still evolving, so it is better to distinguish between policy, professional duty, and legal responsibility rather than assuming they are identical. The safest interpretation is that automation can inform care, but it does not absorb responsibility for care.
Another common failure mode is over-reliance on the model when patient preference is recorded but not operationalised. If the system keeps surfacing recommendations that conflict with documented preferences, teams should treat that as a governance issue, not just a usability issue. The question is not whether the AI is “right” in isolation. It is whether the organisation can show that the final decision process remained patient-centred, reviewable, and clinically accountable.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST CSF 2.0, NIST AI RMF, NIST SP 800-63 and CIS Controls v8 set the technical controls, while ISO/IEC 42001:2023 define the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | GV.OV-01 — Oversight | Clinically used AI needs governance that preserves accountable human oversight. |
| Recommendation — Define oversight for AI-assisted care decisions and keep accountability with named human reviewers. | ||
| NIST AI RMF | GOVERN — Govern | The question is fundamentally about AI governance and responsibility assignment. |
| Recommendation — Assign decision authority, escalation rules, and accountability for AI outputs before clinical use. | ||
| ISO/IEC 42001:2023 | 5.2 — AI policy | Health providers need organisational AI policy to define acceptable use and responsibility. |
| Recommendation — Set an AI policy that states who may rely on, override, and document clinical AI recommendations. | ||
| NIST SP 800-63 | IAL — Identity proofing | Accountability in patient-facing decisions depends on verified roles and authoritative human identity. |
| Recommendation — Verify the identity and role of the clinician who accepts or overrides the AI recommendation. | ||
| CIS Controls v8 | 6.3 — Access Control Management | Clinicians need controlled authority to review and override AI outputs in governed workflows. |
| Recommendation — Restrict override authority to approved clinical roles and log every exception to the AI advice. | ||
Practitioner Guidance
What to prioritise: Define the review-and-override path before the tool is used in routine care. If a recommendation can affect diagnosis, treatment, consent, or discharge decisions, it should never appear as an unowned suggestion.
What to verify: Confirm that the care record captures the recommendation, the clinician’s judgment, the patient preference where relevant, and the reason for any override. If that evidence is missing, accountability is already weakened.
Common mistake: Treating “AI-supported” as if it were a defence for following the output automatically. Experienced teams know that the hardest cases are the ones where the model is persuasive but the context says otherwise.
Practitioner takeaway: The safest operating model is to make the AI advisory, the clinician accountable, and the organisation responsible for proving that disagreement with the model was handled deliberately rather than by default.
Related resources from NHI Mgmt Group
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 7, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
